Taurine prevents tamoxifen-induced mitochondrial oxidative damage in mice

Basic and Clinical Pharmacology and Toxicology

Volumn 102, Issue 4, 2008, Pages 382-387

  Parvez, Suhel ^a,b   Tabassum, Heena ^a,c   Banerjee, Basu Dev ^c   Raisuddin, Sheikh ^a,d  

^a HAMDARD UNIVERSITY   (India)

^b UNIVERSITY OF HAWAII   (United States)

^c UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^d Hanyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL DERIVATIVE; SUPEROXIDE; TAMOXIFEN; TAURINE; THIOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; LIPID PEROXIDATION; LIVER CELL DAMAGE; LIVER MITOCHONDRION; MALE; MITOCHONDRIAL RESPIRATION; MITOCHONDRIAL TOXICITY; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION;

ANIMALS; ANTIOXIDANTS; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDATION; MALE; MICE; MITOCHONDRIA, LIVER; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN CARBONYLATION; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SULFHYDRYL COMPOUNDS; SUPEROXIDE DISMUTASE; SUPEROXIDES; TAMOXIFEN; TAURINE; UNCOUPLING AGENTS;

ANIMALIA; MUS;

EID: 40849086351     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2008.00208.x     Document Type: Article

References (40)

1. Desai PB, Nallani SC, Sane RS et al. Induction of cytochrome P450 3A4 in primary human hepatocytes and activation of the human pregnane X receptor by tamoxifen and 4-hydroxytamoxifen. Drug Metab Dispos 2002 30 : 608 12.
2. Tabassum H, Rehman H, Banerjee BD, Raisuddin S, Parvez S. Attenuation of tamoxifen-induced hepatotoxicity by taurine in mice. Clin Chim Acta 2006 370 : 129 36.
3. Farrell GC. Drugs and steatohepatitis. Semin Liver Dis 2002 22 : 185 94.
4. Bruno S, Maisonneuve P, Castellana P et al. Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial. BMJ 2005 330 : 932.
5. Begriche K, Igoudjil A, Pessayre D, Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 2006 6 : 1 28.
6. Tuquet C, Dupont J, Mesneau A, Roussaux J. Effects of tamoxifen on the electron transport chain of isolated rat liver mitochondria. Cell Biol Toxicol 2000 16 : 207 19.
7. Cardoso CMP, Custodio JBA, Almeida LM, Moreno AJM. Mechanisms of the deleterious effects of tamoxifen on mitochondrial respiration rate and phosphorylation efficiency. Toxicol Appl Pharmacol 2001 176 : 145 52.
8. 2+ and inorganic phosphate. Toxicol Appl Pharmacol 1998 152 : 10 7.
9. Custodio JB, Almeida LM, Madeira VM. The active metabolite hydroxytamoxifen of the anticancer drug tamoxifen induces structural changes in membranes. Biochim Biophys Acta 1993 1153 : 308 14.
10. Nazarewicz RR, Zenebe WJ, Parihar A et al. Tamoxifen induces oxidative stress and mitochondrial apoptosis via stimulating mitochondrial nitric oxide synthase. Cancer Res 2007 67 : 1282 90.
11. El-Beshbishy HA. The effect of dimethyl dimethoxy biphenyl dicarboxylate (DDB) against tamoxifen-induced liver injury in rats: DDB use is curative or protective. J Biochem Mol Biol 2005 38 : 300 6.
12. Tabassum H, Parvez S, Rehman H, Banerjee BD, Raisuddin S. Catechin as an antioxidant in liver mitochondrial toxicity: inhibition of tamoxifen-Induced protein oxidation and lipid peroxidation. J Biochem Mol Toxicol 2007 21 : 110 7.
13. Peralta EA, Viegas ML, Louis S, Engle DL, Dunnington GL. Effect of vitamin E on tamoxifen-treated breast cancer cells. Surgery 2006 140 : 607 14.
14. Tabassum H, Parvez S, Rehman H, Dev Banerjee B, Siemen D, Raisuddin S. Nephrotoxicity and its prevention by taurine in tamoxifen induced oxidative stress in mice. Hum Exp Toxicol 2007 26 : 509 18.
15. Huxtable RJ. Physiological actions of taurine. Physiol Rev 1992 72 : 101 63.
16. Pushpakiran G, Mahalakshmi K, Viswanathan P, Anuradha CV. Taurine prevents ethanol-induced alterations in lipids and ATPases in rat tissues. Pharmacol Rep 2005 57 : 578 87.
17. Nakashima T, Taniko T, Kuriyama K. Therapeutic effect of taurine administration on carbon tetrachloride-induced hepatic injury. Jpn J Pharmacol 1982 32 : 583 9.
18. Saad SY, Al-Rikabi AC. Protection effects of taurine supplementation against cisplatin-induced nephrotoxicity in rats. Chemotherapy 2002 48 : 42 8.
19. Sayeed I, Parvez S, Winkler-Stuck K et al. Patch clamp reveals powerful blockade of the mitochondrial permeability transition pore by the D2-receptor agonist pramipexole. FASEB J 2006 20 : 556 8
20. Hissin PJ, Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976 74 : 214 26.
21. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968 25 : 192 205.
22. Flohe L, Otting F. Superoxide dismutase assays. Methods Enzymol 1984 105 : 93 104.
23. Flohe L, Gunzler WA. Assays of glutathione peroxidase. Methods Enzymol 1984 105 : 114 21.
24. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978 52 : 302 10.
25. 10 intake on endogenous coenzyme Q content, mitochondrial electron transport chain, antioxidative defenses, and life span of mice. Free Radic Biol Med 2006 40 : 480 7.
26. Madesh M, Balasubramanian KA. A microtiter plate assay for superoxide using MTT reduction method. Indian J Biochem Biophysics 1997 34 : 535 9.
27. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976 72 : 248 54.
28. Calabrese V, Lodi R, Tonon C et al. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. J Neurol Sci 2005 233 : 145 62.
29. Meister A. Glutathione metabolism. Methods Enzymol 1995 251 : 3 7.
30. Fromenty B, Pessayre D. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther 1995 67 : 101 54.
31. Pessayre D, Mansouri A, Fromenty B. Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2002 282 : G193 9.
32. Schonfeld P, Reiser G. Rotenone-like action of the branched-chain phytanic acid induces oxidative stress in mitochondria. J Biol Chem 2006 281 : 7136 42.
33. Chang L, Xu J, Yu F, Zhao J, Tang X, Tang C. Taurine protected myocardial mitochondria injury induced by hyperhomocysteinemia in rats. Amino Acids 2004 27 : 37 48.
34. Sinha M, Manna P, Sil PC. Taurine, a conditionally essential amino acid, ameliorates arsenic-induced cytotoxicity in murine hepatocytes. Toxicol In Vitro 2007 21 : 1419 28.
35. Pasantes-Morales H, Cruz C. Taurine and hypotaurine inhibit light-induced lipid peroxidation and protect rod outer segment structure. Brain Res 1985 330 : 154 7.
36. Vissers MC, Fantone JC. Inhibition of hypochlorous acid-mediated reactions by desferrioxamine. Implications for the mechanism of cellular injury by neutrophils. Free Radic Biol Med 1990 8 : 331 7.
37. Chang KJ, Yu CH, Son M. Effects of dietary taurine supplementation on hepatic morphological changes of rats in diethylnitrosamine-induced hepatocarcinogenesis. Adv Exp Med Biol 2003 526 : 253 9.
38. Saransaari P, Oja SS. Taurine and neural cell damage. Amino Acids 2000 19 : 509 26.
39. Waters E, Wang JH, Redmond HP, Wu QD, Kay E, Hayes DB. Role of taurine in preventing acetaminophen-induced hepatic injury in the rats. Am J Physiol 2001 280 : 1274 9.
40. Erdem A, Gundogan NU, Usubutun A et al. The protective effect of taurine against gentamicin-induced acute tubular necrosis in rats. Nephrol Dial Transplant 2000 15 : 1175 82.